Learning & Performance Objectives
This course is designed for allergists, immunologists, pulmonologists, primary care and family practice physicians, otolaryngologists, pediatricians, internists, dermatologists, nurse practitioners, physician assistants, nurses and all allied health professionals who care for patients with allergic and immunologic illnesses.
The goal of this live seminar is to increase knowledge, competence and performance in the management of allergic diseases including urticaria, asthma, allergic rhinitis, contact dermatitis, chronic sinus disease, food allergy, drug allergy, dermatitis, hereditary angioedema, anaphylaxis, autoimmunity and immunodeficiency. A team approach with this learning environment having physicians, nurses, and allied health professionals learning side by side in this CME course.
At the conclusion of this activity, participants will be able to:
- Develop strategies for evaluation and management of drug hypersensitivity.
- Distinguish allergic and non-allergic causes of itch, determine appropriate management strategies.
- Review the pathophysiology, clinical manifestations, evaluation, diagnosis, and management of allergic rhinitis, asthma, and chronic rhinosinusitis.
- Identify strategies to evaluate and treat severe asthma in special populations, particularly, in preschool children and those with aspirin exacerbated respiratory disease.
- Describe the role, indications, and side effects of biologic medications in management of asthma and other allergic diseases.
- Review the updated recommendations for prevention of peanut allergy and new emerging therapies for treatment of food allergy.
- Develop strategies for evaluation and management of challenging cases of anaphylaxis.
- Review the treatment options available management of for hereditary angioedema.
- Describe how IgG4 related autoimmune disease may manifest clinically, and the appropriate steps in diagnosis.
- Discuss the modalities for diagnosis of common variable immunodeficiency, such as genetic testing, and review available options for immunoglobulin replacement.
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credits awarded for the Activity:
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is awarded up to 12.5 ANCC contact hours.
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.
This activity is supported in part by various commercial organizations. A complete list of commercial supporters and contributors will be available at the time of the conference. Some companies may also exhibit.